Immunological perspectives in prevention and treatment of nosocomial pneumonia
- 1 January 1992
- journal article
- review article
- Published by Springer Nature in Intensive Care Medicine
- Vol. 18 (1) , S35-S38
- https://doi.org/10.1007/bf01752975
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Pseudomonas aeruginosa immunotherapyEuropean Journal of Clinical Microbiology & Infectious Diseases, 1990
- TUMOUR NECROSIS FACTOR IN BRONCHOPULMONARY SECRETIONS OF PATIENTS WITH ADULT RESPIRATORY DISTRESS SYNDROMEPublished by Elsevier ,1989
- Compartmentalization of Intraalveolar and Systemic Lipopolysaccharide-Induced Tumor Necrosis Factor and the Pulmonary Inflammatory ResponseThe Journal of Infectious Diseases, 1989
- Impact of molecular biology on Pseudomonas aeruginosa immunizationJournal of Hospital Infection, 1988
- Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemiaNature, 1987
- Einsatz von Pseudomonas-Immunglobulin bei beatmeten Patienten einer interdisziplinären chirurgischen IntensivstationInfection, 1987
- Efficacy of intravenous immune globulin for treatment of experimental pseudomonas aeruginosa pneumoniaJournal of Critical Care, 1986
- PREVENTION OF GRAM-NEGATIVE SHOCK AND DEATH IN SURGICAL PATIENTS BY ANTIBODY TO ENDOTOXIN CORE GLYCOLIPIDThe Lancet, 1985
- Protective activity of an intravenous immune globulin (human) enriched in antibody against lipopolysaccharide antigens of Pseudomonas aeruginosaThe American Journal of Medicine, 1984
- Prevention of gram-negative bacillary pneumonia using polymyxin aerosol as prophylaxis. II. Effect on the incidence of pneumonia in seriously ill patients.Journal of Clinical Investigation, 1975